$1.450
+0.096 (+6.62%)Al cierre
Noticias de HKPD
Eventos de HKPD
Cellyan Biotechnology Files $200M Mixed Securities Shelf
Cellyan Biotechnology files $200M mixed securities shelf
Cellyan Biotechnology Files to Sell 12.5M Class A Ordinary Shares
Cellyan Biotechnology Co. files to sell 12.5M Class A ordinary shares for holder
Hong Kong Pharma opens at $3.50, IPO priced at $4 per share
Hong Kong Pharma Digital Technology Holdings, a provider of OTC pharmaceutical cross-border e-commerce supply chain services in Hong Kong, priced its initial public offering of an aggregate of 1,403,685 ordinary shares at a public offering price of $4.00 per share, of which 1M shares are offered by Hong Kong Pharma and 403,685 shares are offered by the selling shareholders of the company. The shares have begun trading on the Nasdaq Capital Market under the ticker symbol "HKPD". Bancroft Capital is acting as the lead underwriter.
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.